Members of the TRP community
We're currently populating this list!
Come back soon for a more comprehensive list.
One of the most important parts of the TRP is the diversity of the people you will meet. From your cohort to committee members, mentors and patients, one of the key skills you will build will be the ability to network and collaborate with people from very diverse backgrounds.
Some of the people you may meet while in the program are listed below. These are all people who have played a role in the website such as discussants, who come in to talk to students and discuss ideas, to mentors and those who play a role in capstone research projects. We also list, where able, our alumni.
Christopher A. Klinger, Palliative Care Translator Instructor Pallium Canada
Christopher is a Research Scientist with Pallium Canada and chairs the National Initiative for the Care of the Elderly’s (NICE) End-of-Life Issues Theme Team, a knowledge transfer network dedicated to enhancing the care of older adults in Canada and abroad. He also chairs the Quality End-of-Life Care Coalition of Canada’s (QELCCC) Research and Knowledge Translation Committee, a group of national stakeholder organizations concerned about quality end-of-life care.
He is a knowledgeable and experienced educator and has presented at numerous conferences. He regularly teaches courses on aging, health systems/policy research methods and public administration.
Here at the TRP, Chris leads the Student-led Work and Research Module (SWARM) and is a Co-Instructor for the Methods in Practices and Contexts course. View Dr. Klinger's faculty profile.
Claudia Dos Santos, Critical Care Intensivist, Clinician-Scientist, Professor of Medicine, Co-Founder and Scientific Officer NorthMiRs
Follow Claudia Dos Santos on LinkedIn
Dr. Claudia dos Santos' major research interest is acute lung injury. This can be caused by either biomolecular or biophysical insults to the lungs, such as an infection or the mechanical injury resulting from mechanical ventilation itself. Her lab is dedicated to understanding the interaction between patients and the breathing machine and finding new ways to identify individuals, who are at higher risk for developing lung injury, diagnose, treat and monitor improvement from injury.
To accomplish their goals, they have developed various model systems from basic epithelial cell stretch models to animal models of lung injury. They exploit whole genome approaches, such as microarray technology, to identify novel molecular targets and use various computational strategies to analyze our data. They are also interested in understanding how and why critically ill patients develop multi-organ failure. To answer some of the more complex questions her lab also collaborates actively with clinical researchers involved in state of the art clinical trials related to novel mechanical ventilation strategies.
Daniel Mueller, Psychiatrist, Scientist and Professor
Follow Daniel Mueller on LinkedIn
Dr. Mueller’s overarching goal is to improve drug treatment of psychiatric disorders. Pharmacogenetics holds the promise to identify gene variants that are associated with response and side effects. Once validated, this approach will allow for precision medicine avoiding long trial-and-error strategies before the right drug for the right patient is identified.
Dr. Mueller started his position at CAMH in 2008, where he began to assess patients’ CYP2D6 and CYP2C19 gene variants in order to optimize treatment with antidepressants and antipsychotic medication. This clinic is one of the first in psychiatry worldwide and the gene panel has since then been extended.
A particular focus of Dr. Mueller’s research is to target genetic markers that predict medication side effects such as antipsychotic-induced weight gain (AIWG). Dr. Mueller’s research has revealed significant associations between AIWG and, the cannabinoid-1 receptor (Tiwari et al., 2010) gene, the melanocortin-4-receptor (MC4R) gene (Chowdhury et al., 2013 and Malhotra et al., 2012), the dopamine D2 receptor gene (Müller et al., 2012), and the neurpeptide-Y gene (Tiwari et al., 2013). Dr. Mueller’s research group is currently developing an algorithm that will incorporate these genes along with clinical and demographic risk factors in order to develop a genetic risk model of AIWG for clinical application.
Dr. Angela Jerath, Associate Professor, University of Toronto Department of Anesthesiology and Pain Medicine
Dr. Jerath's research and teaching interests lie within the disciplines of critical care medicine and cardiac anesthesia.
Key areas of research include:
- the use and safety of volatile agents for critical care sedation
- development of gas scavenging techniques within the intensive care unit
- tranexamic acid pharmacokinetic modeling for cardiac surgical patients using the technique of solid phase microextraction.
She maintains a key education interest in perioperative echocardiography and has taught in many critical care transthoracic ultrasound courses, co-produced a 3D transesophageal handbook and created teaching modules for the University of Toronto’s Perioperative Interactive Education (PIE) website. Dr. Jerath is an active volunteer in overseas educational courses and engaged in physician training in Nepal and Ethiopia.
Capstone committee member
Dr. Daniel McIsaac, Professor, University of Ottawa
- Lead Scientist, Aging Innovation in Perioperative Medicine & Surgery Research Group
- Professor, University of Ottawa
- Scientist, Ottawa Hospital Research Institute
- Director of Anesthesiology and Pain Medicine Research, The Ottawa Hospital
- Senior Scientist, Institute for Clinical Evaluative Sciences (ICES)
- Staff Anesthesiologist, The Ottawa Hospital
Dr. McIsaac's faculty profile at the University of Ottawa